http://www.unboundmedicine.com/medline/ebm/research/abciximabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19925035/full_citation/Influence_of_Some_Cardiovascular_Risk_Factors_on_the_Expression_of_Platelet_Glycoprotein_IIb/IIIa_Receptors_in_Patients_with_Myocardial_Infarction_Treated_with_Antiplatelet_Drugs_under_Primary_Percutaneous_Coronary_Intervention_Konopka A, Spychalska J, Piotrowski W, et al. 
Influence of Some Cardiovascular Risk Factors on the Expression of Platelet Glycoprotein IIb/IIIa Receptors in Patients with Myocardial Infarction Treated with Antiplatelet Drugs under Primary Percutaneous Coronary Intervention. [JOURNAL ARTICLE]
Mol Diagn Ther 2009 Dec 1; 13(6):375-382.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19921103/full_citation/Impact_of_distal_embolization_on_myocardial_perfusion_and_survival_among_patients_undergoing_primary_angioplasty_with_glycoprotein_IIb_IIIa_inhibitors:_insights_from_the_EGYPT_cooperation_De Luca G, Gibson CM, Bellandi F, et al. 
Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. [JOURNAL ARTICLE]
J Thromb Thrombolysis 2009 Nov 17.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19918189/full_citation/A_multicenter_randomized_study_to_evaluate_intracoronary_abciximab_with_the_ClearWay_catheter_to_improve_outcomes_with_Lysis__IC_ClearLy_:_trial_study_design_and_rationale_Sardella G, Sangiorgi GM, Mancone M, et al. 
A multicenter randomized study to evaluate intracoronary abciximab with the ClearWay catheter to improve outcomes with Lysis (IC ClearLy): trial study design and rationale. [JOURNAL ARTICLE]
J Cardiovasc Med (Hagerstown) 2009 Nov 13.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19904011/full_citation/Enhancement_of_fibrinolysis_by_gel_filtered_platelets_and_its_quenching_by_cytochalasin_B_and_GPIIb/IIIa_antagonists_Hoki S, Suzuki Y, Umemura K, et al. 
Enhancement of fibrinolysis by gel-filtered platelets and its quenching by cytochalasin B and GPIIb/IIIa antagonists. [JOURNAL ARTICLE]
Pharmacol Rep 2009 September-October; 61(5):877-884.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884334/full_citation/Human_platelets_recognize_a_novel_surface_protein_PadA_on_Streptococcus_gordonii_through_a_unique_interaction_involving_fibrinogen_receptor_GPIIbIIIa_Petersen HJ, Keane C, Jenkinson HF, et al. 
Human platelets recognize a novel surface protein PadA on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. [JOURNAL ARTICLE]
Infect Immun 2009 Nov 2.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19882074/full_citation/Glycoprotein_IIb/IIIa_antagonists_Zeymer U, Zahn R 
Glycoprotein IIb/IIIa antagonists. [Journal Article]
Hamostaseologie 2009 Sep; 29(4):334-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19875386/full_citation/Risk_profile_and_benefits_from_Gp_IIb_IIIa_inhibitors_among_patients_with_ST_segment_elevation_myocardial_infarction_treated_with_primary_angioplasty:_a_meta_regression_analysis_of_randomized_trials_De Luca G, Navarese E, Marino P 
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. [JOURNAL ARTICLE]
Eur Heart J 2009 Oct 28.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19863970/full_citation/Successful_intra_arterial_thrombolysis_beyond_the_accepted_6_hour_time_window_in_two_young_patients_Coster S, van Dijk LC, Treurniet FE, et al. 
Successful intra-arterial thrombolysis beyond the accepted 6-hour time window in two young patients. [JOURNAL ARTICLE]
J Neurol Sci 2009 Oct 26.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19861121/full_citation/A_Novel_Ultrasound_Based_Method_to_Evaluate_Hemostatic_Function_of_Whole_Blood_Viola F, Mauldin FW, Lin-Schmidt X, et al. 
A Novel Ultrasound-Based Method to Evaluate Hemostatic Function of Whole Blood. [JOURNAL ARTICLE]
Clin Chim Acta 2009 Oct 24.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19850249/full_citation/Benefit_of_Facilitated_Percutaneous_Coronary_Intervention_in_High_Risk_ST_Segment_Elevation_Myocardial_Infarction_Patients_Presenting_to_Nonpercutaneous_Coronary_Intervention_Hospitals_Herrmann HC, Lu J, Brodie BR, et al. 
Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals. [Journal Article]
JACC Cardiovasc Interv 2009 Oct; 2(10):917-24.
Abstract | Full Citation | Find Related Articles